Skip to main content
. 2010 Jun 17;2010:102758. doi: 10.1155/2010/102758

Figure 1.

Figure 1

Polyepitope DNA-based cancer vaccines and cross-antigen presentation. After injection of the recombinant polyepitope DNA vaccine into myocyte or keratinocytes, antigenic materials is transferred to dendritic cells (antigen cross-presentation).